SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: Adenine Base Editing of APOE4 to APOE3 for Alzheimer's Preve

idea 705 words KG: Repair 2026-03-24

kind:idea kind:therapy-idea section:ideas state:published

Contents

Adenine Base Editing of APOE4 to APOE3 for Alzheimer's Prevention

Knowledge Graph

Related Hypotheses (27)

APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53

Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.49 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 APOE Isoform Conversion Therapy
Score: 0.44 Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Microbial Inflammasome Priming Prevention
Score: 0.58 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48 APOE-TREM2 Interaction Modulation
Score: 0.48 Cross-Seeding Prevention Strategy
Score: 0.45 LRP1-Dependent Tau Uptake Disruption
Score: 0.44 TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 Pharmacological Enhancement of APOE4 Glycosylation
Score: 0.37

Related Analyses (24)

APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived APOE4-driven lipid metabolism dysregulation in astrocytes an
neuroscience · failed Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived Neuroinflammation and microglial priming in early AD
neurodegeneration · completed Do APOE4-driven senescent astrocytes cause neurodegeneration
neurodegeneration · failed

How does APOE4 mechanistically increase TDP-43 pathology fre
neurodegeneration · failed Which specific metabolic pathways in APOE4+ microglia are mo
neurodegeneration · completed Mechanistic validation of SEA-AD differential expression hyp
neurodegeneration · failed Do these mechanistic hypotheses explain layer-specific synap
neurodegeneration · failed Do these mechanistic hypotheses from the SEA-AD Atlas bundle
neurodegeneration · failed Which specific metabolic pathways in APOE4 microglia are cau
neurodegeneration · failed Does structural 'normalization' of APOE4 domain interactions
neurodegeneration · failed What is the high-resolution structure of the APOE4 hinge reg
structural biology · failed How does APOE4's beneficial immune function reconcile with i
neurodegeneration · completed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed

Related Experiments (16)

AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 ApoE4 Function in Alzheimer's Disease
validation · proposed · Score: 0.40 Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40 Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.40

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40 Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88 Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.40 Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.40 Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40

See Also (15)

APOE4 (Apolipoprotein E4)
disease · Pages share 8 hypotheses APOE3 (Apolipoprotein E3)
disease · Pages share 8 hypotheses APOE2 (Apolipoprotein E2)
disease · Pages share 8 hypotheses UPenn Observational Research Repository (NCT04715399)
clinical · Pages share 8 hypotheses remternetug-anti-amyloid-alzheimers
clinical_trial · Pages share 8 hypotheses

ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 8 hypotheses nct05508789
clinical_trial · Pages share 8 hypotheses LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 8 hypotheses LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 8 hypotheses BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 7 hypotheses Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses WNK1 Kinase in Neurodegeneration
mechanism · Pages share 6 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 6 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 6 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 6 hypotheses

Knowledge Graph (1 edges)

Repair involved_in Lysosome Quality Control

SciDEX — scidex.ai — Dashboard | Atlas